NO20053517D0 - Use of lipid-lowering agents - Google Patents

Use of lipid-lowering agents

Info

Publication number
NO20053517D0
NO20053517D0 NO20053517A NO20053517A NO20053517D0 NO 20053517 D0 NO20053517 D0 NO 20053517D0 NO 20053517 A NO20053517 A NO 20053517A NO 20053517 A NO20053517 A NO 20053517A NO 20053517 D0 NO20053517 D0 NO 20053517D0
Authority
NO
Norway
Prior art keywords
lipid
lowering agents
bmd
lowering
fibrate
Prior art date
Application number
NO20053517A
Other languages
Norwegian (no)
Other versions
NO20053517L (en
Inventor
Rolf Kristian Berge
Original Assignee
Thia Medica As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica As filed Critical Thia Medica As
Priority to NO20053517A priority Critical patent/NO20053517L/en
Publication of NO20053517D0 publication Critical patent/NO20053517D0/en
Priority to PCT/NO2006/000263 priority patent/WO2007011232A2/en
Publication of NO20053517L publication Critical patent/NO20053517L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen omfatter anvendelse av et fibrat og/eller forbindelsen Wyeth 14,643 for fremstilling av en farmakologisk sammensetning for forebygging og/eller behandling av tilstander assosiert med lav/senket beinmineraltetthet (BMD) og/eller for økning av BMD ved senkning av beinresorpsjon.The invention comprises the use of a fibrate and / or the compound Wyeth 14,643 for the manufacture of a pharmacological composition for the prevention and / or treatment of conditions associated with low / decreased bone mineral density (BMD) and / or for increasing BMD by lowering bone resorption.

NO20053517A 2005-07-18 2005-07-18 Use of lipid-lowering agents NO20053517L (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO20053517A NO20053517L (en) 2005-07-18 2005-07-18 Use of lipid-lowering agents
PCT/NO2006/000263 WO2007011232A2 (en) 2005-07-18 2006-07-10 Lipid lowering agents for increasing bmd

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20053517A NO20053517L (en) 2005-07-18 2005-07-18 Use of lipid-lowering agents

Publications (2)

Publication Number Publication Date
NO20053517D0 true NO20053517D0 (en) 2005-07-18
NO20053517L NO20053517L (en) 2007-01-19

Family

ID=35295501

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053517A NO20053517L (en) 2005-07-18 2005-07-18 Use of lipid-lowering agents

Country Status (2)

Country Link
NO (1) NO20053517L (en)
WO (1) WO2007011232A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2040694A2 (en) * 2006-07-14 2009-04-01 VIB vzw Use of ppar-alpha agonists to treat skeletal muscle wasting disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10053003A1 (en) * 1999-10-19 2001-06-28 Univ Jw Goethe Frankfurt Main Treatment of immunologically induced skin disorders, skin aging or neuropathy, comprises using peroxisome-proliferator activated receptor, alpha, beta activators such as pirinixic acid
GB0003310D0 (en) * 2000-02-15 2000-04-05 Univ Sheffield Bone formation

Also Published As

Publication number Publication date
WO2007011232A3 (en) 2007-06-07
NO20053517L (en) 2007-01-19
WO2007011232A2 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
NO20082090L (en) Pyridopyrimidinone inhibitors of P13K alpha
PL376409A1 (en) Composition for the treatment of infection by flaviviridae viruses
UA92355C2 (en) urn:schemas-microsoft-com:office:smarttags2,4-DIAMINO-PYRIMIDINES USED AS AURORAINHIBITORS
HK1112910A1 (en) Compounds and methods for the treatment or prevention of flavivirus infections
ATE550037T1 (en) COMPOSITIONS AGAINST THE SARS CORONAVIRUS AND THEIR USES
WO2007120980A3 (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
NO20070933L (en) Indazoles useful in the treatment of cardiovascular diseases
TW200720268A (en) 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors
EA200601552A1 (en) SUBSTITUTED CONDENSED HETEROCYCLIC C-GLYCOSIDES
TNSN07252A1 (en) Indole derivatives for treating viral infections
MXPA05012680A (en) Novel substituted 3-sulfur indoles.
TW200508228A (en) Biaryl heterocyclic compounds and methods of making and using the same
NO20063479L (en) Phosphonates, monophosphonamidates and bisphosphonamidates for the treatment of viral diseases
TW200734311A (en) New compounds
EA200601648A1 (en) GLUCOSAMINE AND GENERAL PROCEDURES GLUCOSAMINE / ANTI-INFLAMMATORY AGENT, COMPOSITIONS AND METHODS
TW200722100A (en) A therapeutic agent for a β related disorders
TW200621753A (en) Pyrimidinylimidazoles and methods of making and using the same
ATE534652T1 (en) PHOSPHONO-PENT-2-EN-1-YL NUCLEOSIDES AND ANALOGS
UA86599C2 (en) Substituted benzimidazole-, benztriazole- and benzimidazolone-о-glucosides
ATE413388T1 (en) MUSCARINE ANTAGONISTS
WO2007059230A3 (en) Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
NO20052529L (en) Compound and composition, and use of the same
TW200716566A (en) Prokineticin 2 receptor antagonists
TW200724140A (en) Hydantoin compounds
TW200745039A (en) Isotopically substituted pantoprazole

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application